Skip to main content

NeuBase Therapeutics, Inc.

NBSEDelisted May 16, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001173281

NeuBase Therapeutics, Inc. was delisted on May 16, 2024; its insiders filed their last Form 4 on Sep 18, 2023; 18 institutions reported holding it in 13F filings for Q1 2024, worth $177.1K in total; Greenlight Capital was the only superinvestor holding it.

13F holders, Q4 2021

Institutional positions in NeuBase Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
46
−2 vs. Q3 2021
Shares held
11.2M
+1.11M (+11.0%) vs. Q3 2021
Total value
$31.6M
−$4.99M (−13.6%) vs. Q3 2021
New holders
6
10 more added
Sold out
8
11 more reduced

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NBSE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 46 institutions
Q1 2021: 57 institutionsQ2 2021: 59 institutionsQ3 2021: 48 institutionsQ4 2021: 46 institutionsQ1 2022: 45 institutionsQ2 2022: 43 institutionsQ3 2022: 44 institutionsQ4 2022: 35 institutionsQ1 2023: 36 institutionsQ2 2023: 26 institutionsQ3 2023: 20 institutionsQ4 2023: 21 institutionsQ1 2024: 18 institutionsQ2 2024: 2 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2021: $31.6M
Q1 2021: $59.4MQ2 2021: $51.5MQ3 2021: $36.6MQ4 2021: $31.6MQ1 2022: $23.3MQ2 2022: $13.4MQ3 2022: $4.74MQ4 2022: $1.94MQ1 2023: $1.72MQ2 2023: $1.08MQ3 2023: $301.2KQ4 2023: $340.2KQ1 2024: $177.1KQ2 2024: $4.95KQ3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding NBSE and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20242$4.95K
Q1 202418$177.1K
Q4 202321$340.2K
Q3 202320$301.2K
Q2 202326$1.08M
Q1 202336$1.72M
Q4 202235$1.94M
Q3 202244$4.74M
Q2 202243$13.4M
Q1 202245$23.3M
Q4 202146$31.6M
Q3 202148$36.6M
Q2 202159$51.5M
Q1 202157$59.4M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding NeuBase Therapeutics, Inc.; share changes are against Q3 2021.

Institutions holding NBSE in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Greenlight Capital Inc2,727,027$7.66M0.47%00.0%Unchanged
Vanguard Group Inc1,364,634$3.83M0.00%−1,696−0.1%Reduced
Point72 Asset Management, L.P.1,250,000$3.51M0.02%00.0%Unchanged
AIGH Capital Management LLC1,000,285$2.81M0.88%+1,000,285New
Carnegie Mellon University939,412$2.64M1.06%+939,412New
Sio Capital Management, LLC906,445$2.55M0.78%00.0%Unchanged
Polar Asset Management Partners Inc.634,618$1.78M0.02%00.0%Unchanged
Jacob Asset Management of New York LLC426,424$1.20M0.53%+18,924+4.6%Added
Prelude Capital Management, LLC311,000$874.0K0.04%00.0%Unchanged
Geode Capital Management, LLC243,984$685.0K0.00%+4,165+1.7%Added
Worth Venture Partners, LLC229,253$644.0K0.32%+229,253New
CM Management, LLC150,000$422.0K0.32%+75,000+100.0%Added
Renaissance Technologies LLC122,386$344.0K0.00%−268,807−68.7%Reduced
Deutsche Bank AG100,000$281.0K0.00%00.0%Unchanged
Bank of New York Mellon Corp87,210$245.0K0.00%00.0%Unchanged
Goldman Sachs Group Inc82,391$232.0K0.00%−22,405−21.4%Reduced
BlackRock Inc.78,512$220.0K0.00%−3,204−3.9%Reduced
Royal Bank of Canada69,682$196.0K0.00%+37,097+113.8%Added
State Street Corp58,013$163.0K0.00%00.0%Unchanged
Northern Trust Corp54,926$154.0K0.00%00.0%Unchanged
Tocqueville Asset Management L.P.53,500$150.0K0.00%−20,500−27.7%Reduced
Davenport & Co LLC48,500$136.0K0.00%−10,000−17.1%Reduced
Two Sigma Advisers, LP40,090$113.0K0.00%−138,731−77.6%Reduced
Susquehanna International Group, LLP33,532$94.0K0.00%−30,216−47.4%Reduced
Perkins Capital Management Inc30,000$84.0K0.06%+9,000+42.9%Added
Citadel Advisors LLC29,528$83.0K0.00%+29,528New
Millennium Management LLC27,252$77.0K0.00%−948−3.4%Reduced
Waldron Private Wealth LLC20,088$56.0K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)19,945$56.0K0.00%+18,521+1,300.6%Added
Fifth Lane Capital, LP20,000$56.0K0.03%+20,000New
Bank of America Corp16,462$47.0K0.00%−3,774−18.6%Reduced
Oppenheimer & Co Inc15,750$44.0K0.00%+5,400+52.2%Added
Heritage Wealth Advisors10,000$28.0K0.00%+10,000New
Morgan Stanley9,417$26.0K0.00%−50,813−84.4%Reduced
Simplex Trading, LLC8,324$23.0K0.00%+3,431+70.1%Added
UBS Group AG7,436$21.0K0.00%+2,254+43.5%Added
Cubist Systematic Strategies, LLC6,317$18.0K0.00%+1,792+39.6%Added
Optiver Holding B.V.3,210$12.0K0.00%00.0%Unchanged
Eaton Vance Management750$2.00K0.00%00.0%Unchanged
The PNC Financial Services Group, Inc.427$1.00K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.450$1.00K0.00%00.0%Unchanged
Wells Fargo & Company190$1.00K0.00%00.0%Unchanged
Global Wealth Management Investment Advisory, Inc.250$1.00K0.00%00.0%Unchanged
Newbridge Financial Services Group, Inc.250$1.00K0.00%00.0%Unchanged
Ancora Advisors, LLC100$00.00%00.0%Unchanged
Ritter Daniher Financial Advisory, LLC2$00.00%00.0%Unchanged
Gsa Capital Partners LLP0$00.00%−351,178−100.0%Sold out
Stonepine Capital Management, LLC0$00.00%−109,742−100.0%Sold out
Two Sigma Investments, LP0$00.00%−85,796−100.0%Sold out
Ergoteles LLC0$00.00%−74,552−100.0%Sold out
Marshall Wace, LLP0$00.00%−50,310−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−44,801−100.0%Sold out
HRT Financial LP0$00.00%−27,056−100.0%Sold out
JPMorgan Chase & Co0$00.00%−385−100.0%Sold out